Share of people with HIV who receive antiretroviral therapy in Slovakia
Slovakia: Share of people with HIV who receive antiretroviral therapy was 65.0% in 2018. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Slovakia, 2000–2018
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
The most recent figure for share of people with hiv who receive antiretroviral therapy in Slovakia is 65.0%, measured in 2018.
The figure is down 9.7% on the previous year and up 124.1% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Slovakia peaked at 72.0% in 2017 and was at its lowest, 7.0%, in 2000.
That places Slovakia 93rd out of 143 countries with data for 2018, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Slovakia, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 7.0% | — |
| 2001 | 8.0% | +14.3% |
| 2002 | 8.0% | +0.0% |
| 2003 | 10.0% | +25.0% |
| 2004 | 28.0% | +180.0% |
| 2005 | 25.0% | -10.7% |
| 2006 | 34.0% | +36.0% |
| 2007 | 32.0% | -5.9% |
| 2008 | 29.0% | -9.4% |
| 2009 | 31.0% | +6.9% |
| 2010 | 33.0% | +6.5% |
| 2011 | 34.0% | +3.0% |
| 2012 | 39.0% | +14.7% |
| 2013 | 44.0% | +12.8% |
| 2014 | 49.0% | +11.4% |
| 2015 | 55.0% | +12.2% |
| 2016 | 57.0% | +3.6% |
| 2017 | 72.0% | +26.3% |
| 2018 | 65.0% | -9.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 21.2% | 7.0% | 34.0% | 10 |
| 2010s | 49.8% | 33.0% | 72.0% | 9 |
Countries ranked near Slovakia
More health data for Slovakia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9332 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,433 deaths per 1,000 people (2090)
- Number of infants who die before age 1 28 deaths (2100)
- Population ages 30-34, female, annual growth rate -4.44 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0322 units per person (2025)
- Population ages 30-34, male, annual growth rate -4.49 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0335 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Slovakia?
- Share of people with hiv who receive antiretroviral therapy in Slovakia was 65.0% in 2018, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Slovakia?
- The highest recorded value was 72.0% in 2017.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Slovakia?
- The lowest recorded value was 7.0% in 2000.
- How does Slovakia rank for share of people with hiv who receive antiretroviral therapy?
- Slovakia ranks 93rd out of 143 countries with data for 2018.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Slovakia?
- Over the last ten years it is up 124.1%. The long-run trend across the full record is volatile.
- Where does this Slovakia data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.